Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01290835 · ClinicalTrials.gov registry record · NA
Conformal Partial Breast Irradiation With CyberKnife After Resection for Early Stage Breast Cancer
A NA study, sponsored by Essentia Health.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01290835 is a NA study that has completed, run by Essentia Health. The registered enrollment target is 20 participants.
The verdict
NCT01290835, a NA study, has completed, sponsored by Essentia Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if it is feasible, safe, and effective to use Cyberknife radiotherapy to deliver partial breast radiotherapy after lumpectomy.Patients meeting eligibility criteria will be invited to participate. Adjuvant radiotherapy will be delivered using CyberKnife radiotherapy using twice daily sessions for five days for a total of ten sessions. Short-term and long-term toxicity will be assessed as well as Tumor control and site of failure (if any).
Interventions
- RADIATION Stereotactic radiotherapy delivered by CyberKnife
- RADIATION stereotactic radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-06 |
| Est. Completion | 2025-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01290835
The ClinicalTrials.gov registry entry for NCT01290835 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Essentia Health, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stereotactic radiotherapy delivered by CyberKnife is the first listed.
NCT01290835 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01290835 about?
NCT01290835 is a clinical study titled "Conformal Partial Breast Irradiation With CyberKnife After Resection for Early Stage Breast Cancer". The purpose of this study is to determine if it is feasible, safe, and effective to use Cyberknife radiotherapy to deliver partial breast radiotherapy after lumpectomy.Patients meeting eligibility criteria will be invited to participate. Adjuvant radiotherapy will be delivered using CyberKnife radio...
What is the current status of trial NCT01290835?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2010-06. Estimated completion is 2025-08.
What interventions are being tested in trial NCT01290835?
The interventions under investigation include: Stereotactic radiotherapy delivered by CyberKnife (RADIATION), stereotactic radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT01290835?
This trial is sponsored by Essentia Health, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.